Literature DB >> 11507104

Suppression of allograft rejection in the sponge Suberites domuncula by FK506 and expression of genes encoding FK506-binding proteins in allografts.

W E Müller1, R Steffen, B Lorenz, R Batel, M Kruse, A Krasko, I M Müller, H C Schröder.   

Abstract

Porifera (sponges) are, evolutionarily, the oldest metazoan phylum. Recent molecular data suggest that these animals possess molecules similar to and homologous with those of the innate and adaptive immune systems of higher Metazoa. Applying the biological system of parabiosis and the technique of differential display of mRNA, two cDNAs encoding putative FK506-binding proteins were isolated. FK506 is successfully used in clinics as a drug to prevent allograft rejection and is toxic to Suberites domuncula cells in vitro at doses above 100ng ml(-1). Autograft fusion of transplants from S. domuncula was not affected by FK506. Allograft non-fusion was not affected by FK506 at toxic doses; however, at the non-toxic dose of 20ng ml(-1), the allografts fused with each other. It is shown that at the attachment zone in untreated and (particularly drastic) in FK506-treated allografts, expression of the genes encoding the FK506-binding proteins is upregulated. These data indicate that the drug FK506 suppresses allograft rejection in S. domuncula, most probably via interaction with expression of the gene coding for the FK506-binding proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507104     DOI: 10.1242/jeb.204.13.2197

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  3 in total

1.  Transcriptomic Profiling of the Allorecognition Response to Grafting in the Demosponge Amphimedon queenslandica.

Authors:  Laura F Grice; Bernard M Degnan
Journal:  Mar Drugs       Date:  2017-05-11       Impact factor: 5.118

2.  Traditional and Modern Biomedical Prospecting: Part I-the History: Sustainable Exploitation of Biodiversity (Sponges and Invertebrates) in the Adriatic Sea in Rovinj (Croatia).

Authors:  Werner E. G. Müller; Renato Batel; Heinz C. Schröder; Isabel M. Müller
Journal:  Evid Based Complement Alternat Med       Date:  2004-06-01       Impact factor: 2.629

3.  Traditional and Modern Biomedical Prospecting: Part II-the Benefits: Approaches for a Sustainable Exploitation of Biodiversity (Secondary Metabolites and Biomaterials from Sponges).

Authors:  Werner E G Müller; Heinz C Schröder; Matthias Wiens; Sanja Perović-Ottstadt; Renato Batel; Isabel M Müller
Journal:  Evid Based Complement Alternat Med       Date:  2004-09-01       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.